With the recommended phase 2 regimen, a response occurred in 80% of the patients (including in 61% of those with extramedullary ... relapsed or refractory multiple myeloma. We conducted an ongoing ...

The patient, based in Shanghai, was first detected with multiple myeloma in 2008. Whilst he underwent treatments from chemotherapy to stem cell transplantations, he relapsed with extramedullary ...

Opens in a new tab or window A novel combination for relapsed/refractory multiple ... System III myeloma, six of eight with high-risk cytogenetics, and 11 of 18 with extramedullary disease.